Results 231 to 240 of about 19,462,706 (409)

Clinical medicine to social medicine

Industrial Psychiatry Journal, 2018
Bhat, PookalaShivaram, Ventriglio, Antonio, Bhugra, Dinesh, Srivastava, Kalpana   +3 more
openaire   +4 more sources

Defining Critical Emergency Medicine (CrEM): A Delphi Study From Scandinavia. [PDF]

Acta Anaesthesiol Scand
Bäckström D, Tommila M, Pedersen M, Lindner T, Kruse N, Larsen R.   +5 more
europepmc   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

The Library\u27s New Home Page, Vol. 12 (1) Jauary - February 1999 [PDF]

, 1999
Houston Academy of Medicine-Texas Medical Center Library
core   +1 more source

Author Correction: Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape. [PDF]

Nat Neurosci
Dubey A, Yamashita E, Stangeland B, Abbas I, Fooksman D, Harris RA, Palmer GM, Koba WR, Zhang J, Himes BT, Lu OR, Ho WS, Kuiper RV, Huffman D, Wu Z, Uchida Y, Ishii M, Welch RL, Fiedler AF, Reynolds D, Hosainey SAM, Dobrenis K, Ye Q, Fisher K, Killian N, Stanley ER, Eskandar E, Behnan J.   +27 more
europepmc   +1 more source

TREX1, a predator for treating MSI‐H tumors?

Molecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya, Joséphine Deneft, Marc Van den Eynde   +2 more
wiley   +1 more source

Library Online Catalog Relocated, Vol.5 (1) January - February 2007 [PDF]

, 2007
Houston Academy of Medicine-Texas Medical Center Library
core   +1 more source

Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

New England Journal of Medicine, 1993
D. Eisenberg, R. Kessler, C. Foster, F. Norlock, D. Calkins, T. Delbanco   +5 more
semanticscholar   +1 more source

Network medicines™

Journal of Translational Medicine, 2023
openaire   +3 more sources

New initiative in SLEEP: Perspectives in sleep science and sleep medicine. [PDF]

Sleep
Adamantidis A, Gozal D, Stone K, Pack AI.   +3 more
europepmc   +1 more source